Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2004, p. 4581-4585, Vol. 42, No. 10
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.10.4581-4585.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Clinical Microbiology Laboratory, Duke University Medical CenterDepartments of,1 Pathology,2 Medicine, Duke University School of Medicine, Durham, North Carolina,3 Microbiology Laboratory, Robert Wood Johnson University HospitalDepartments of,4 Medicine,5 Pathology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey6
Received 27 April 2004/ Returned for modification 14 June 2004/ Accepted 24 June 2004
|
|
|---|
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Comparison of medium formulations for BacT/ALERT FAN, FN, and SN anaerobic media
|
|
|
|---|
Adequacy of blood volume. Upon receipt in the laboratory, the volume of fluid in each bottle was measured against a volume standard to determine how many milliliters of blood had been inoculated into each of the bottles. All bottles were processed regardless of the volume of blood received. Only bottle sets containing 8 to 12 ml of blood were included in the data analysis.
Bottle processing. Bottles from each culture set were placed in the BacT/ALERT instrument and incubated for 5 days or until they signaled positive. Bottles flagged by the instrument as positive were removed, and an aliquot of the blood broth mixture was removed from the bottle with a sterile needle and syringe. A portion was used for a Gram stain, and the remainder was subcultured onto solid plate medium according to the results of the Gram stain. Subsequent microbial isolation, identification, and antimicrobial susceptibility testing were performed according to standard techniques (5). Gram stain-negative bottles were returned to the instrument for the remainder of the 5-day incubation period or until reflagged by the instrument. These Gram stain-negative bottles that were flagged by the instrument were considered false-positive bottles if no microorganisms were isolated on subculture. Negative companion bottles from positive sets were subcultured at the end of the 5-day protocol. Bottles that were instrument negative but grew a microorganism on subculture were considered false-negative bottles.
Clinical assessment. Each positive culture was reviewed by one of the physician investigators and coded as a true positive, a contaminant, or an isolate of unknown clinical importance. These assessments were made in accord with published criteria (7). True positives were defined as microorganisms that are considered pathogens when isolated from patients with signs and symptoms of disease or potential pathogens that were isolated from multiple cultures within a 48-h period. Contaminants were defined as single positive cultures for a microorganism usually considered a contaminant in the absence of a plausible source (e.g., coagulase-negative staphylococci from a febrile patient without a central venous catheter), single positive cultures for a microorganism usually considered a contaminant when there was a plausible source (e.g., central venous catheter) but the patient was clinically well (surveillance cultures), or single positive cultures for a microorganism usually considered a contaminant when several others drawn within the same time frame were negative. Isolates of unknown significance were defined as single cultures for a potential pathogen (e.g., coagulase-negative staphylococci, viridans streptococci, or enterococci) or a usual contaminant (e.g., Bacillus spp., diphtheroids, Lactobacillus spp., or Micrococcus spp.) in a symptomatic patient who had a plausible source but for whom only one culture was submitted to the laboratory.
An episode of bacteremia or fungemia was defined as a period beginning with the first positive blood culture and ending when 7 days (2 days for coagulase-negative staphylococci) had passed without another positive blood culture with the same microorganism, regardless of whether negative cultures were done in the intervening days (7). When a different clinically significant isolate was detected within 3 days of the first isolate, the episode was considered polymicrobial. Patients were considered to be on effective therapy if the antimicrobial agent given at the time that the blood culture was drawn was either known or presumed (based on usual in vitro susceptibility patterns if testing was not routinely done) to inhibit the microorganism isolated.
Data analysis. Comparison of recovery rates from the bottles was done with the chi-square test of McNemar (3). Yates' correction was used when n was less than 20. Comparison of times to positivity between bottles was performed only where both bottles were positive within 72 h.
|
|
|---|
|
View this table: [in a new window] |
TABLE 2. Comparative yield of clinically important isolates in FN versus SN anaerobic blood culture bottles
|
|
View this table: [in a new window] |
TABLE 3. Comparative yield of clinically important isolates in FN versus SN anaerobic blood culture bottles from patients on antimicrobial therapy
|
|
View this table: [in a new window] |
TABLE 4. Comparative yield of clinically important isolates in FN versus SN anaerobic blood culture bottles from patients not on antimicrobial therapy
|
When analyzed by septic episode, S. aureus, Enterobacteriaceae, and all microorganisms combined were found more frequently in FN blood culture sets than in SN (Table 5).
|
View this table: [in a new window] |
TABLE 5. Comparative yield of clinically important unimicrobial episodes of bacteremia and fungemia by FN versus SN anaerobic blood culture bottles paired with an FA bottle
|
|
View this table: [in a new window] |
TABLE 6. Comparative time to positivity in FN versus SN blood culture bottles detected within 72 h
|
There were 31 (14 from FN and 17 from SN) clinically significant isolates detected when instrument-negative companion bottles from positive sets (false negative) were subcultured. Subcultures from FN detected Chryseobacterium meningosepticum (1 isolate) and P. aeruginosa (13 isolates). The isolates detected in subcultures from SN bottles were S. aureus (one isolate), coagulase-negative staphylococci (two isolates), Enterobacter cloacae (one isolate), Acinetobacter baumannii (two isolates), Burkholderia cepacia (two isolates), C. meningosepticum (one isolate), P. aeruginosa (three isolates), Pseudomonas oryzihabitans (two isolates), Stenotrophomonas maltophilia (one isolate), and Candida parapsilosis (two isolates). All false-negative isolates from FN or SN bottles were detected in the companion FA bottle.
Microorganisms determined to be contaminants (primarily coagulase-negative staphylococci) were isolated more frequently from FN than from SN (both bottles = 71, FN bottle only = 136, SN bottle only = 71; P < 0.001).
|
|
|---|
The original anaerobic FAN medium for the BacT/ALERT system was formulated to improve the recovery of microorganisms over that with the anaerobic standard medium when inoculated with blood from adult patients. The overall improved performance of the anaerobic FAN versus the standard medium was shown in a controlled multicenter clinical comparison by our group in an earlier publication (10). The study presented herein showed that the new FN formulation also outperformed the present SN medium. Both the anaerobic FAN and FN showed improved isolation of staphylococci, Enterobacteriaceae, and all microorganisms overall compared with standard media; however, the new FN medium also showed improved performance for recovery of anaerobic bacteria. In both the earlier and present studies the standard anaerobic media gave higher yields for nonfermenters and yeasts. However, in the present study when the yields from the combined FA-FN set and from FA-SN were considered, these differences were no longer present for either nonfermenters or yeasts. This is to be expected, since these microorganisms are recovered optimally from an aerobic medium.
In our earlier study (10), the mean time to detection of positive culture results was delayed in FAN by almost 2 h compared with the standard anaerobic medium, whereas the present FN medium detected microorganisms overall sooner by a mean of 1.4 h than did the standard anaerobic medium. This difference was most marked for isolates of S. aureus, which were detected a mean of 3.4 h sooner. In both studies the same criterion of comparing positives in the first 72 h (more than 95% of comparisons) was used in order to avoid the bias of outliers.
Analysis of septic episodes in controlled clinical comparisons of blood culture media reduces potential bias from multiple positive cultures on an individual patient that consistently favors one bottle or the other. Both the earlier anaerobic FAN (10) study and the present FN study showed that more episodes of bacteremia were detected when either the anaerobic FAN or FN bottle was used than when standard medium was used. In addition, in the present study, we evaluated the detection of septic episodes by comparing results from FA-FN and from FA-SN sets, which also showed the superiority of the FN to the SN. These results are consistent with the improved recovery of charcoal-containing media that was shown to have clinical importance by McDonald et al. (2).
There were fewer false positives with FN than were previously found with anaerobic FAN bottles (10), which suggests that medium modifications or instrument algorithms have been modified successfully by the BacT/ALERT system to minimize this problem. Moreover, in the present study, the FN bottle showed fewer false-positive results and had fewer false-negative results than did the SN bottle. False-negative FN bottles grew primarily P. aeruginosa, which is known to grow poorly, if at all, in anaerobic media and is recovered most often from aerobic bottles. In contrast, isolates from false-negative SN bottles represented a wide range of species.
Isolates determined to be contaminants were found significantly more frequently in the FN medium. This was not seen in our previous evaluation of the anaerobic FAN medium (10) but was noted in earlier studies of the aerobic FAN medium (6). The enhanced detection of positive blood cultures, especially with staphylococci, in both charcoal-containing (1, 6, 10) and resin-containing (8, 9) media includes not only clinically important isolates but also contaminants (2). Thus, clinical microbiologists must weigh both the benefits and limitations of various blood culture medium formulations for continuously monitored instruments when selecting a blood culture system for routine use.
We gratefully acknowledge the assistance of the laboratory and research staff of the Clinical Microbiology Laboratory at Duke University Medical Center and Robert Wood Johnson University Hospital.
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»